ClinicalTrials.gg
Drug

BAY987521 clinical trials

Also written BAY987521.

studies test it
13
open now
0
in phase 3
0
first study started
2015

How each study uses BAY987521 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

BAY987521
13

Studies by the year they started

13 studies that test it; most in 2016 (6)

Studies that test BAY987521, by start year
YearStudies
20153
20166
20174

By phase

A phase 1/2 study counts in both.

No phase
13

Who runs them

Industry 13 · Other 0

Bayer (13)

Studies

Open first, then newest update. How each study uses BAY987521 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13